Disease Markers / 2016 / Article / Tab 3

Research Article

Is Urinary NGAL Determination Useful for Monitoring Kidney Function and Assessment of Cardiovascular Disease? A 12-Month Observation of Patients with Type 2 Diabetes

Table 3

Characteristics of 30 T2DM patients with available follow-up data at the beginning of the study (baseline results) and after 12-month follow-up (control results).

Baseline resultsControl results

BMI, kg/m230.9 ± 5.531.4 ± 5.70.6
, %7.98 ± 1.996.31 ± 0.930.037
Hemoglobin, g/dL14.2 ± 1.413.9 ± 1.40.019
WBC, 103/μL7.59 ± 2.397.34 ± 2.670.5
Total cholesterol, mmol/L5.38 (4.11–5.95)4.78 (4.01–5.86)0.3
LDL-cholesterol, mmol/L3.10 (2.07–3.75)2.62 (1.98–3.94)0.3
HDL-cholesterol, mmol/L1.32 (1.01–1.53)1.36 (1.03–1.49)0.1
Triglycerides, mmol/L1.57 (1.13–1.89)1.53 (1.16–2.03)0.5
Serum creatinine, μmol/L68.1 (60.1–76.9)69.0 (61.9–77.8)0.035
eGFR, mL/min/1.73 m294.4 (79.7–98.3)87.0 (74.6–99.0)0.023
Albuminuria, mg/L8.53 (6.59–13.53)5.55 (2.14–19.75)0.2
uACR, mg/g7.49 (3.39–13.38)4.69 (2.86–43.41)0.1
uNGAL, μg/L18.00 (9.00–32.20)9.35 (2.50–19.30)0.018
uNCR, μg/g16.18 (10.00–33.72)8.82 (3.09–26.83)0.037
Leukocyturia, 3 (10)5 (17)0.4

LDL, low-density lipoprotein; HDL, high-density lipoprotein; see Table 1.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.